In an exciting breakthrough, scientists at UCLA's Jonsson Comprehensive Cancer Center recently reported an encouraging increase in progression-free survival (or PFS, the length of time a patient is on treatment without tumor growth) for patients with HER2-negative breast cancer, a particularly aggressive form of the disease. In this informative video, lead researcher Dr. Richard Finn explains the positive results of this pioneering study and the possibilities it opens up for future breast cancer treatments.
UCLA's Jonsson Comprehensive Cancer Center is among the nation's top 10 cancer centers (US News & World Report). The JCCC has established an international reputation for pioneering the development of revolutionary targeted therapies.
Plastic surgery is a medical specialty concerned with the correction or restoration of form and function. Though cosmetic or aesthetic surgery is the best-known kind of plastic surgery, most plastic surgery is not cosmetic.
Kevin Carlberg overcame a brain tumor (glioblastoma) thanks to a dendritric cell vaccine developed at UCLA's Jonsson Comprehensive Cancer Center and the care of his physician, Dr. Linda Liau.
UPDATE 8/31/2009: Kevin Carlberg suffered a recurrence of his cancer and, despite treatment, he passed away on Saturday, August 29, 2009. Through his participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Carlberg lived about four times longer than the average glioblastoma patient. His participation also helped move cancer research forward. We thank him.
Meet cancer patients and family members touched by new therapies developed at UCLA's Jonsson Cancer Center. Features appearances by Ryan Seacrest, Khloe Kardashian and the Kardashian family, Denise and Peter Wittich, Laura Felkai, and Meritt Carlberg, the widow of cancer patient Kevin Carlberg.
UPDATE: Laura Felkai suffered a recurrence of her cancer and, despite treatment, she passed away in June, 2011 Through her participation in a clinical trial at UCLA's Jonsson Comprehensive Cancer Center, Felkai lived longer and enjoyed a better quality of life than the average melanoma patient. Her participation also helped move cancer research forward. We thank her.
Jonsson Comprehensive Cancer Center's Dr. Dennis Slamon and his "dream team" of researchers are profiled for CBS 2 News Central. He discusses how pioneering research at UCLA is shaking up traditional methods in breast cancer therapy, targeting and tailoring treatment for patients by cancer subtype.